dijous, 8 de maig del 2014

HRS2014: Boston Scientific's S-ICD strong at 22 months, promising in post-ICD patients




Boston Scientific's S-ICD continues to demonstrate safety and efficacy at 22 months following implant, with more promising results for patients getting the S-ICD following an infection with a previous implant.





HRS2014: Boston Scientific's S-ICD strong at 22 months, even in post-ICD patients

Boston Scientific, Heart Rhythm Society

News Well, Cardiac Implants, Cardiac Rhythm Management, Conference coverage, HRS 2014

read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1itKcjl
Publicat per a
Etiquetes de comentaris: ,

Cap comentari:

Publica un comentari a l'entrada

Subscriure's a: Comentaris del missatge (Atom)